Twin study of women in their 40s with a history of acne
Metrics
Apolipoprotein A1 (ApoA1):
Odds ratio: 0.71 (95% CI: 0.51-1.00)
p-value: 0.05
Finding: Lower levels of ApoA1 are associated with increased odds of being in the case group. This relationship is statistically significant at the conventional threshold.
OCP (Oral Contraceptive Pill) use:
Odds ratio: 1.75 (95% CI: 1.08-2.08)
p-value: 0.02
Finding: Ever using OCPs is associated with significantly higher odds of being in the case group.
From discussion:
Apolipoprotein A1 (ApoA1):
"Low serum levels of Apo A1 was the only significant risk factor for acne using the cross-sectional and co-twin case–control design."
Oral Contraceptive Pill (OCP) use:
"Rather than being causal, this association is likely to be explained by the fact that OCP is one of the therapeutic options for acne." This suggests that OCP use may be a consequence of having acne (as a treatment) rather than a risk factor for developing it.
Age and timing of measurements:
The researchers caution about interpreting their results, noting: "The results of the case–control analyses have to be taken with caution, however, as the measurements were made many years after the disease was active and possible associations with acne may have been missed because of this interval." This addresses our earlier discussion about the participants being in their 40s.
Bataille, V et al. “The influence of genetics and environmental factors in the pathogenesis of acne: a twin study of acne in women.” The Journal of investigative dermatology vol. 119,6 (2002): 1317-22. doi:10.1046/j.1523-1747.2002.19621.x
e158dbad-6ccd-432a-b249-881f0b27844a (edited)